China Botanic Pharmaceutical Inc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

CBPI 0.00020 0.00000 (0.00%)
price chart
China's Market For Vitamin And Mineral Supplements Face Challenge From Old ...
Traditional medicines China An employee works at a traditional Chinese medicine shop in Shanghai, China, September 16, 2015.
Injecting hope into cancer fight
The first viral immunotherapy was approved 10 years ago in China, a cold virus engineered to treat head and neck cancer. China became a mecca for ... "It's a signal to pharmaceutical companies that such drugs can be approved." The treatment is ...
DEA eases requirements for natural cannabis-derived drug research
Pioneering the effort is Britain's GW Pharmaceuticals, which is slated next year to deliver the results of four late-stage U.S.
Toads Skin, Herbs Feed China's $2.7 Billion Cancer Fight
It brought in about 1.5 billion yuan last year for Zhejiang Kanglaite Pharmaceutical Co., its closely held manufacturer, which aims to complete late-stage trials in the U.S.. Other drugmakers are seeking ways to integrate traditional Chinese medicines ...
Toads, arsenic and herbs feed China's US$2.7b cancer fight  Malay Mail Online
Harvard Endowment's Sweeping Overhaul
In his first annual letter, disseminated in September, Harvard Management Company (HMC) president and CEO Stephen Blyth described both sluggish recent investment returns and—far more consequentially—significant changes in asset allocation and ...
Avail Vapor offers glimpse into the 'art and science' of e-liquids
Avail co-founder Donovan Phillips said the clean room was designed to be a pharmaceutical-grade production area. He describes the viewing area as like going to a Krispy Kreme store to watch donuts being made, instead of just buying a box at a grocery ...
Your daily 6: Trouble for drug company boss, 'affluenza' teen and ex-NBA star
... 32, who was taken into custody at his New York City residence, is currently the boss of Turing Pharmaceuticals. He was previously the manager of hedge fund MSMB Capital Management and chief executive of biopharmaceutical company Retrophin Inc.
Why We Should All Care About The Amazon's Disappearing Tribes
Despite the fact that 25 percent of modern pharmaceuticals are derived from rainforest plants, less than 1 percent of tropical plants have been analyzed for medical purposes.
Paulson Among New Yorkers Getting Merry at City's Holiday Bashes
Ackman's Pershing Square Holdings, the publicly traded part of his activist hedge fund, lost 20.5 percent last year, hurt in part by a drop in the shares of drugmaker Valeant Pharmaceuticals International Inc. Einhorn's Greenlight Capital suffered the ...
In a boom year for mergers, deals-driven hedge funds are burned by bad bets
The big problem was that many of the stocks that were widely held by event-driven funds turned out be clunkers this year, including drug company Valeant Pharmaceuticals, which plunged more than 55 percent after short-sellers and lawmakers raised ...